Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
02/19/2009 | DE102008031478A1 Detektion von Wasser in Kraftstoff mit Hilfe von Arbeitszyklusberechnung Detection of water in fuel using duty cycle calculation |
02/19/2009 | DE102007038777A1 Zellkulturmesssystem und Verfahren für vergleichende Untersuchungen an Zellkulturen Cell culture measuring system and method for comparative studies on cell cultures |
02/19/2009 | DE102007038730A1 Nachweis des menschlichen Vascular Endothelial Growth Factor Detection of the human Vascular Endothelial Growth Factor |
02/19/2009 | DE102007037008A1 Diagnosesubstanz zur Anwendung in einem Verfahren zur Bestimmung der Aggressivität eines Prostatatumors und Diagnoseverfahren Diagnostic substances for use in a method for determining the aggressiveness of a prostate tumor and diagnostic methods |
02/19/2009 | DE102007036437A1 Method for producing application data for low stress annealing of attached series components made of metal, particularly in motor vehicle, involves connecting multiple individual units having solid or tubing material by arc welding |
02/19/2009 | DE102005050167B4 Konzentrationsverfahren, Konzentrationsvorrichtung und Reaktionsverfahren Concentration method, concentrator and response procedures |
02/19/2009 | CA2733672A1 Tumor cell-derived microvesicles |
02/19/2009 | CA2700923A1 Novel targets and compounds for therapeutic intervention of hiv infection |
02/19/2009 | CA2696843A1 Method, system and software arrangement for comparative analysis and phylogeny with whole-genome optical maps |
02/19/2009 | CA2696364A1 Article, device, and method |
02/19/2009 | CA2696360A1 Monoclonal antibody 175 targeting the egf receptor and derivatives and uses thereof |
02/19/2009 | CA2696047A1 A method for identifying, expanding, and removing adult stem cells and cancer stem cells |
02/19/2009 | CA2695994A1 Use of c3 to c14 aliphatic aldehydes, ketones and primary and secondary c3 to c7 aliphatic alcohols to inhibit sprouting of potato tubers |
02/19/2009 | CA2694863A1 Agents and methods for modulating macrophage inhibitory cytokine (mic-1) activity |
02/19/2009 | CA2686465A1 Antibodies and improved test sample handling methods for use in assays for myeloperoxidase |
02/19/2009 | CA2684873A1 Anti-bacterial drug targeting of genome maintenance interfaces |
02/18/2009 | EP2026074A2 Centrifugal force-based microfluidic device for nucleic acid detection and microfluidic system including the same |
02/18/2009 | EP2026073A1 Diagnostics and therapeutics for macular degeneration-related disorders |
02/18/2009 | EP2026072A1 Cromatographic assay system |
02/18/2009 | EP2026071A2 Identification of cancer protein biomarkers using proteomic techniques |
02/18/2009 | EP2026070A1 Methods of diagnosing cervical cancer |
02/18/2009 | EP2026069A1 Container for determining particle agglutination |
02/18/2009 | EP2026068A1 Method for producing purified and/or concentrated analytes, use and kit |
02/18/2009 | EP2026067A1 Method for detection of disease having insulin-resistant condition |
02/18/2009 | EP2026064A2 Flue Gas Analyser comprising an electrochemical oxygen sensor |
02/18/2009 | EP2026060A1 Optical detection apparatus based on phase-shift interferometry |
02/18/2009 | EP2025762A2 Heteroduplex tracking assay |
02/18/2009 | EP2025754A2 Moraxella (Branhamella) catarrhalis antigens |
02/18/2009 | EP2025753A2 Phagemid for screening antibodies |
02/18/2009 | EP2025750A1 Novel targets and compounds for therapeutic intervention of HIV infection |
02/18/2009 | EP2025749A1 Humanized anti-human osteopontin antibody |
02/18/2009 | EP2025744A1 Method and system for counting the cells in a biological culture medium on line and in situ |
02/18/2009 | EP2025686A2 Alpha anticholine kinase monoclonal antibodies and their use in analytical techniques for the diagnosis of cancer and the preparation of medicinal products |
02/18/2009 | EP2024893A2 A laser illumination system in fluorescent microscopy |
02/18/2009 | EP2024888A1 Information management techniques for metabolism-related data |
02/18/2009 | EP2024757A1 System and methods for actuation on magnetoresistive sensors |
02/18/2009 | EP2024748A2 Monoclonal anti-annexin a3 antibodies for the detection of prostate carcinoma |
02/18/2009 | EP2024747A1 Use of protein satb2 as a marker for colorectal cancer |
02/18/2009 | EP2024746A2 Use of gpr101 receptor in methods to identify modulators of hypothalamic proopiomelanocortin (pomc)-derived biologically active peptide secretion useful in the treatment of pomc-derived biologically active peptide-related disorders |
02/18/2009 | EP2024745A2 Assays for diagnosing and evaluating treatment options for fabry disease |
02/18/2009 | EP2024744A1 Microtiter plate and use thereof |
02/18/2009 | EP2024743A1 A method for measuring breath temperature in breath alcohol testing |
02/18/2009 | EP2024742A2 System and method for preparing samples |
02/18/2009 | EP2024740A1 Method for detection and classification of imperfections in components by means of ultrasound |
02/18/2009 | EP2024727A1 Method for determining the viability of cells in cell cultures |
02/18/2009 | EP2024520A1 Method of protein extraction from cells |
02/18/2009 | EP2024512A2 Methods for the diagnosis of fetal abnormalities |
02/18/2009 | EP2024511A1 Cholesterol-regulating complex of sirt1 and lxr and methods of use |
02/18/2009 | EP2024509A1 Detection method |
02/18/2009 | EP2024500A1 Gene family (lbfl313) associated with pancreatic cancer |
02/18/2009 | EP2024497A2 Liga and ligb proteins (leptospiral ig-like (lig) domains) for vaccination and diagnosis |
02/18/2009 | EP2024488A2 Metal-enhanced chemiluminescence (mec) |
02/18/2009 | EP2024393A2 Neutralizing antibodies to influenza viruses |
02/18/2009 | EP2024386A2 Use of proteins and peptides of the tgf-beta superfamily for purification and therapeutic methods |
02/18/2009 | EP2024362A1 Iap bir domain binding compounds |
02/18/2009 | EP2023897A1 Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof |
02/18/2009 | EP2023874A2 Methods for identifying agents and their use for the prevention of restenosis |
02/18/2009 | EP2023802A2 Test sensor with under-fill protection |
02/18/2009 | EP1952149A4 High throughput screening assay for the trpm5 ion channel |
02/18/2009 | EP1952138A4 Method for detecting an inflammatory disease or cancer |
02/18/2009 | EP1913391A4 QUANTITATIVE ASSAYS FOR PDGFR-beta IN BODY FLUIDS |
02/18/2009 | EP1909852A4 Amyloid beta protein channel structure and uses thereof indentifying potential drug molecules for neurodegenerative diseases |
02/18/2009 | EP1899732A4 Shape tunable plasmonic nanoparticles |
02/18/2009 | EP1893997A4 Quantitative assays for ras p21 in body fluids |
02/18/2009 | EP1812792A4 Analysis for glucose products using pyridinylboronic acid |
02/18/2009 | EP1740223A4 Method for characterizing the oxidative stress protective capacity of an antioxidative substance |
02/18/2009 | EP1695086B1 Methods for detecting bacterial pathogens |
02/18/2009 | EP1679372B1 Novel plexin polypeptide, dna encoding the same and use thereof |
02/18/2009 | EP1660634A4 P16 mediated regulation of nmda receptors |
02/18/2009 | EP1618388B1 Proteomic analysis of biological fluids |
02/18/2009 | EP1587409A4 Diagnosis and monitoring of inflammation, ischemia and appendicitis |
02/18/2009 | EP1576368B1 Methods and compositions for enhancing fibrocyte formation |
02/18/2009 | EP1576180B1 Ampk pathway components |
02/18/2009 | EP1573336B1 Prp detection method using a group ii aminoglycoside antibiotic |
02/18/2009 | EP1555325B1 Novel fructosyl peptide oxidase and utilization thereof |
02/18/2009 | EP1552303B1 Biosensor for detecting glucose |
02/18/2009 | EP1507145B1 Biomolecular substrate and test device |
02/18/2009 | EP1489968B1 Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples |
02/18/2009 | EP1456661B1 Binding assay device with non-absorbent carrier material |
02/18/2009 | EP1452865B1 Composition for blood serum or plasma separation and vessel for blood examination containing the same |
02/18/2009 | EP1442291B1 Biological marker for stress states |
02/18/2009 | EP1416055B1 Method of efficiently detecting double-stranded nucleic acid |
02/18/2009 | EP1393136B1 Method for monitoring and detecting sensor failure in oil and gas production system |
02/18/2009 | EP1346034B1 VON WILLEBRAND FACTOR (vWF) CLEAVING PROTEASE POLYPEPTIDE, NUCLEIC ACID ENCODING THE POLYPEPTIDE AND USE OF POLYPEPTIDE |
02/18/2009 | EP1238110B1 Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated rna decay |
02/18/2009 | EP1181554B1 Method for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses |
02/18/2009 | EP1135467B1 Psca: prostate stem cell antigen and uses thereof |
02/18/2009 | EP1104405B1 Near infrared chemiluminescent acridinium compounds and uses thereof |
02/18/2009 | EP1090293B1 Decoding of array sensors with microspheres |
02/18/2009 | EP1071955B2 Improved immunodiagnostic assays using reducing agents |
02/18/2009 | EP0965041B1 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease |
02/18/2009 | EP0941337B1 Synthesis and purification of hepatitis c virus-like particles |
02/18/2009 | CN201196651Y Gold mark detection test paper for double-tumor token |
02/18/2009 | CN201196650Y Portable fast joint inspection device for multiple tumor tokens |
02/18/2009 | CN201196649Y Portable fast joint inspection device for foetus teratogenic disease |
02/18/2009 | CN201196648Y Test device for glucose in urine of diabetes patient |
02/18/2009 | CN201196647Y Pathology material drawing plate |
02/18/2009 | CN201196646Y Environment simulator for asphalt mixture hydrosphere stability test |
02/18/2009 | CN201196645Y Multifunctional track test apparatus |
02/18/2009 | CN201196644Y Asphalt mixture low-temperature fatigue experiment apparatus |